Sumitomo Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History

Sumitomo Life Insurance CO

  • $2.78 Billion
  • Q1 2025

A detailed history of Sumitomo Life Insurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 2,320 shares of REGN stock, worth $1.14 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,320
Previous 3,112 25.45%
Holding current value
$1.14 Million
Previous $2.22 Million 33.62%
% of portfolio
0.05%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
SELL
$634.14 - $744.83 $502,238 - $589,905
-792 Reduced 25.45%
2,320 $1.47 Million
Q4 2024

Jan 23, 2025
SELL
$701.85 - $1046.91 $43,514 - $64,908
-62 Reduced 1.95%
3,112 $2.22 Million
Q3 2024

Oct 16, 2024
BUY
$1024.09 - $1201.76 $1.46 Million - $1.71 Million
1,427 Added 81.68%
3,174 $3.34 Million
Q2 2024

Jul 19, 2024
SELL
$883.2 - $1071.19 $198,720 - $241,017
-225 Reduced 11.41%
1,747 $1.84 Million
Q1 2024

Apr 26, 2024
SELL
$902.69 - $993.35 $71,312 - $78,474
-79 Reduced 3.85%
1,972 $1.9 Million
Q4 2023

Jan 30, 2024
BUY
$775.18 - $881.7 $485,262 - $551,944
626 Added 43.93%
2,051 $1.8 Million
Q3 2023

Oct 23, 2023
SELL
$692.45 - $844.37 $570,578 - $695,760
-824 Reduced 36.64%
1,425 $1.17 Million
Q2 2023

Jul 20, 2023
SELL
$700.03 - $830.35 $135,105 - $160,257
-193 Reduced 7.9%
2,249 $1.62 Million
Q1 2023

Apr 27, 2023
SELL
$680.49 - $826.97 $12,248 - $14,885
-18 Reduced 0.73%
2,442 $2.01 Million
Q4 2022

Jan 17, 2023
SELL
$705.89 - $766.39 $25,412 - $27,590
-36 Reduced 1.44%
2,460 $1.78 Million
Q3 2022

Oct 31, 2022
SELL
$573.97 - $724.32 $164,155 - $207,155
-286 Reduced 10.28%
2,496 $1.72 Million
Q2 2022

Jul 22, 2022
BUY
$548.35 - $738.84 $11,515 - $15,515
21 Added 0.76%
2,782 $1.65 Million
Q1 2022

Apr 27, 2022
SELL
$595.12 - $698.43 $23,804 - $27,937
-40 Reduced 1.43%
2,761 $1.93 Million
Q4 2021

Feb 04, 2022
SELL
$543.48 - $670.97 $58,695 - $72,464
-108 Reduced 3.71%
2,801 $1.77 Million
Q3 2021

Oct 25, 2021
SELL
$574.03 - $680.96 $70,031 - $83,077
-122 Reduced 4.03%
2,909 $1.76 Million
Q2 2021

Jul 20, 2021
SELL
$472.8 - $558.54 $230,726 - $272,567
-488 Reduced 13.87%
3,031 $1.69 Million
Q1 2021

Apr 27, 2021
SELL
$446.73 - $548.2 $76,390 - $93,742
-171 Reduced 4.63%
3,519 $1.67 Million
Q4 2020

Feb 05, 2021
SELL
$478.3 - $607.98 $171,709 - $218,264
-359 Reduced 8.87%
3,690 $1.78 Million
Q3 2020

Oct 29, 2020
SELL
$544.75 - $658.21 $115,487 - $139,540
-212 Reduced 4.98%
4,049 $2.27 Million
Q2 2020

Jul 22, 2020
SELL
$493.32 - $643.92 $195,354 - $254,992
-396 Reduced 8.5%
4,261 $2.66 Million
Q1 2020

May 01, 2020
BUY
$336.18 - $494.43 $21,179 - $31,149
63 Added 1.37%
4,657 $2.27 Million
Q4 2019

Jan 24, 2020
BUY
$274.13 - $376.51 $70,177 - $96,386
256 Added 5.9%
4,594 $1.73 Million
Q3 2019

Oct 24, 2019
SELL
$273.46 - $318.39 $139,191 - $162,060
-509 Reduced 10.5%
4,338 $1.2 Million
Q2 2019

Jul 26, 2019
BUY
$299.6 - $414.82 $51,531 - $71,349
172 Added 3.68%
4,847 $1.52 Million
Q1 2019

Apr 17, 2019
SELL
$372.08 - $439.57 $187,900 - $221,982
-505 Reduced 9.75%
4,675 $1.92 Million
Q4 2018

Jan 24, 2019
BUY
$335.82 - $403.04 $42,313 - $50,783
126 Added 2.49%
5,180 $1.94 Million
Q3 2018

Oct 18, 2018
SELL
$351.14 - $408.51 $35,114 - $40,851
-100 Reduced 1.94%
5,054 $2.04 Million
Q2 2018

Jul 23, 2018
BUY
$284.6 - $344.99 $62,896 - $76,242
221 Added 4.48%
5,154 $1.78 Million
Q1 2018

Apr 27, 2018
SELL
$315.82 - $393.78 $68,532 - $85,450
-217 Reduced 4.21%
4,933 $1.7 Million
Q4 2017

Feb 01, 2018
SELL
$358.63 - $469.95 $90,374 - $118,427
-252 Reduced 4.66%
5,150 $1.94 Million
Q3 2017

Oct 17, 2017
BUY
$431.38 - $504.0 $2.33 Million - $2.72 Million
5,402
5,402 $2.42 Million

Others Institutions Holding REGN

# of Institutions
1,471
Shares Held
85.8M
Call Options Held
1.39M
Put Options Held
1.45M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $52.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sumitomo Life Insurance CO Portfolio

Follow Sumitomo Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email